Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Beam Therapeutics Inc. (BEAM) had Weighted-Average Shares Outstanding (Diluted) of 103.26M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$31.74M |
|
$-94.32M |
|
-- |
|
$31.74M |
|
$138.95M |
|
$-107.22M |
|
$12.90M |
|
$-94.32M |
|
$-94.32M |
|
$-94.32M |
|
$-94.32M |
|
$-94.32M |
|
$-94.32M |
|
$-107.22M |
|
$-104.34M |
|
103.26M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
103.26M |
$-0.91 |
|
$-0.91 |
|
| Balance Sheet Financials | |
$1.27B |
|
$101.25M |
|
$213.84M |
|
$1.48B |
|
$74.56M |
|
$100.19M |
|
$241.79M |
|
$316.36M |
|
$1.16B |
|
$1.16B |
|
$1.16B |
|
102.74M |
|
| Cash Flow Statement Financials | |
$-128.51M |
|
$25.27M |
|
$96.61M |
|
$301.62M |
|
$294.98M |
|
$-6.64M |
|
$19.04M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
16.99 |
|
-- |
|
-- |
|
0.08 |
|
0.09 |
|
100.00% |
|
-337.81% |
|
-337.81% |
|
-- |
|
-297.18% |
|
-297.18% |
|
$-130.75M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
-8.10% |
|
-8.10% |
|
-6.37% |
|
-7.46% |
|
$11.33 |
|
$-1.27 |
|
$-1.24 |
|